Skip to content

Bruker Corp

US · BRKR #1504 by market cap Listed 1970
59.72 -0.78 -1.29%
Live - 5344 symbols - heartbeat 73s ago · 2026-10-08 08:48
Pre-market 59.46 -0.43%
After-hours 60.45 +1.22%
Overnight 59.00 -1.21%
Market cap
9.10B
P/B
3.79
EPS
-0.15
Reader sentiment Are you bullish or bearish on BRKR?

Anonymous reader poll. Unscientific, not investment advice.

About Bruker Corp

Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the following segments: Bruker Scientific Instruments (BSI) BioSpin, BSI Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID), BSI NANO, and Bruker Energy and Supercon Technologies (BEST). The BSI BioSpin segment includes life science tools based on magnetic resonance technology. The BSI CALID segment focuses on life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments, and solutions based on infrared and Raman molecular spectroscopy technologies and radiological and nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection. The BSI NANO segment offers advanced x-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments, analytical tools for electron microscopes and x-ray metrology, defect-detection equipment for semiconductor process control, handheld, portable, and mobile x-ray fluorescence spectrometry instruments, spark optical emission spectroscopy systems, and chip cytometry products and services for targeted spatial proteomics, multi-omics services, and products and services for spatial genomics research. The BEST segment is involved in superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare, and big science research. The company was founded by Emil Bruker and Günther Laukien in 1960 and is headquartered in Billerica, MA.

Founded
1960
CEO
Dr. Frank H. Laukien,PhD
Employees
11,085
Headquarters
Billerica, Massachusetts, United States of America
Fiscal year end
12-31
Website
bruker.com

Company profile

Exchange
US
Symbol
BRKR
Market-cap rank
#1504
Listing date
1970-01-01
Market cap
9.10B
Float cap
6.19B
Shares out
152.36M
Float shares
103.69M

Sectors & themes

Medical Devices Room-Temp Superconductors Global medical industry Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-08 08:48:37 · For reference only, not investment advice and not tailored to your situation.